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Currently, upon understanding the metabolomics of carotenoids, it is important to address the key role of
carotenoid derived products. In this regard, aim of the study was to elucidate and explore the role of
lycopene (LYC) oxidative products generated through autoxidation (AOL) or chemical (KMnO4) oxidation
(COL) against proliferation of selected cancer cells. Preliminary, we investigated the effect of LYC on cell
viability of various cancer cell lines (PC-3, MCF-7, A431, HepG2, HeLa and A549). Based on the results of
LYC treatment on cell cytotoxicity levels, MCF-7, PC-3 and HeLa cell lines were further tested with AOL
and COL products. The decreased cell viability with depleted GSH and increased MDA levels were
observed when treated with COL products than control, LYC and AOL. In addition, COL products increased
ROS levels and percent apoptosis. The typical morphological changes and nuclear condensations showed
that COL products have anti-proliferation and apoptosis inducing activity. Based on results, we hy-
pothesized that ROS generation by LYC oxidation products may be one of intermediate step involved in
apoptosis. The redox status and therapeutic approach of COL products in modulating ROS and induction
of apoptosis in cancer cells were reported for the ﬁrst time, to our knowledge. To conclude, COL products
involves in cancer growth inhibition efﬁciently than intact LYC and AOL. Hence, there is a great potential
for synthesizing or producing such carotenoid oxidation products to augment cancer complication.
© 2016 Elsevier Ltd. All rights reserved.1. Introduction
Epidemiological studies have shown that consumption of ca-
rotenoids rich food are associated with a reduced risk of cancer and
other chronic diseases (Rao and Agarwal, 2000; Giovannucci et al.,
2002; Etminan et al., 2004; Talvas et al., 2010). Among carotenoids,
LYC is one of the highly recognised bioactive compound involved in
inhibition of prostate and other cancers by various mechanisms
(Nahum et al., 2001; Livny et al., 2002; Liu et al., 2003; Tang et al.,
2005; Herzog et al., 2005). The continuous progress in carotenoids
research demonstrates that the biological role of them is attributed
to identiﬁcation of their metabolites or oxidative products (Wang,
2012). In general, carotenoid metabolites are reported to beogy, Jnana Bharathi Campus,
arayana).involved in chemoprevention of cancers. The conversion and bio-
logical signiﬁcance of b-carotene oxidative cleavage products
(retinal, retinoic acid and apo-carotenoids) are well documented in
mammals (Eroglu and Harrison, 2013). Similarly, some progress has
been made on lutein oxidation products and their biofunctional
property (Khachik et al., 1997; Lakshminarayana et al., 2013; Nidhi
et al., 2015). However, information related to metabolism of non-
provitamin A carotenoids like LYC are yet to be described in
detail. Previously, Khachik et al. (1997) identiﬁed carotenoid me-
tabolites in human milk and serum. Subsequently, Kim et al. (2001)
have shown the formation of LYC oxidation products in vitro and
proposed the presence of similar compounds in vivo samples due to
autoxidation. Later, Caris-Veyrat et al. (2003) identiﬁed apo-
lycopenals and apo-lycopenones derived from oxidation of LYC
with potassium permanganate and by atmospheric oxygen cata-
lyzed by a metalloporphyrin. Further, central and eccentric cleav-
ages of LYC in the presence of soy lipoxygenase were identiﬁed in
Abbreviations
LYC Lycopene
AOL Autoxidation lycopene
COL Chemical oxidation lycopene
KMnO4 Potassium per manganate
PC-3 Human prostate cancer cell line
MCF-7 Human breast adenocarcinoma cell line
A431 Human epidermoid carcinoma cell line
HepG2 Human hepatocelluar carcinoma cell line
HeLa Human cervical cancer cell line
A549 Human alveolar epithelial cell line
ROS Reactive oxygen species
DCHF-DADichloro-dihydro-ﬂuorescein diacetate
DAPI,40 6-diamidino-2-phenylindole
BHT Butylated hydroxytoluene
DTNB 5-50-dithiobis [2-nitrobenzoic acid]
MDA Malondialdehyde
EDTA Ethylenediaminetetraacetic acid
NADPH Nicotinamide adenine dinucleotide phosphate
DMEM Dulbecco's minimal essential medium
MEM Minimum essential medium
FBS Fetal bovine serum
MTT 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl
tetrazolium bromide
PBS Phosphate buffer saline
FITC Fluorescein isothiocyanate
CTAB Cetyltrimethylammonium bromide
PVDF Polyvinylidene ﬂuoride
DCM Dichloromethane
UPLC Ultra performance liquid chromatography
PDA Photodiode array
APCI Atmospheric-pressure chemical ionization
H2O2 Hydrogen peroxide
AO/EB Acridine orange/Ethidium bromide
HOCl Hypochlorous acid
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determined the existence of apo-80- lycopenal, apo-120-lycopenal
and other polar metabolites of LYC in rats. Likewise, Kopec et al.
(2010) have shown the presence of a series of apo-lycopenals in
fruits, vegetables and human plasma and anticipated the formation
may be due to enzymatic and chemical oxidative cleavage of LYC.
The discovery of various oxidation products or metabolites of ca-
rotenoids either in vitro or in vivo, have questioned the active role
of them compared to intact carotenoid molecules in ameliorating
various diseases. However, little is known about metabolites or
oxidative products of LYC on health beneﬁts. Nara et al. (2001) have
demonstrated that autoxidation mixtures of LYC inhibited the HL-
60 cell growth effectively than LYC. Similarly, Zhang et al. (2003)
identiﬁed a cleavage product of LYC (E, E, E)-4-methyl-8-oxo-2, 4,
6-nonatrienal, and evaluated its apoptosis-inducing activity in HL-
60 cells. Consequently, Aust et al. (2003) reported the role of LYC
degraded products in enhancing cell communication and cell sig-
nalling. Generally, the process of apoptosis can be initiated by
various physiological and physico-chemical stimuli like oxidants,
ionizing radiation and chemotherapeutic agents. Notably, carot-
enoids are shown to be an effective antioxidant by scavenging
certain reactive oxygen species (ROS), especially peroxyl radicals
and singlet oxygen at low oxygen tension (Burton and Ingold, 1984;
Halliwell, 1999). However, clinical trials of b-carotene supplements
on the incidence of cancer could be non-protective or detrimental
in smokers (Omenn et al., 1996). Therefore, the antioxidant and
anti-carcinogenic properties of carotenoids need to be re-evaluated
at different situations like higher oxygen tension and ROS pro-
duction. It has been suggested that b-carotene or its degradation
products may be pro-oxidant or pro-carcinogenic (Wang and
Robert, 1999). Increased generation of reactive oxygen species
(ROS) and an altered redox status have been observed in cancer
cells, and recent studies suggest that this biochemical property of
cancer cells can be exploited for therapeutic beneﬁts (Prasad et al.,
2006; Cui et al., 2007). Few studies have correlated that, b-carotene
induces apoptosis through ROS intermediates (Prasad et al., 2006;
Cui et al., 2007). LYC is another important non-provitamin A
carotenoid with same molecular mass, chemical formula as b-
carotene and differs structurally by open polyene chain lacking
with b-ionone ring. Hydrocarbon carotenoids like b-carotene and
LYC are known for their superior antioxidant against singlet and
other reactive oxygen species, however, studies have shown themoderate action of these carotenoids on various cancer cell lines in
contrast to the reports of in vivo studies. Previously, Teodoro et al.
(2012) demonstrated that lycopene inhibits cell proliferation and
increased apoptosis effectively in breast, colon and prostate cancer
cells among eight different cancer cell lines. Further, they suggested
effect of lycopene may vary with cellular type, time and dose.
Recently, studies of others including our laboratory have an opinion
that cellular effects of carotenoids are mediated through their de-
rivatives formed either by chemical oxidation or by enzymatic
cleavage in vivo system (Sharoni et al., 2012; Lakshminarayana
et al., 2008, 2013). Hence, elucidation of LYC oxidation products
and evaluation of their biological signiﬁcance is warranted. With
this back ground, the aim of the present study was to investigate
the role of LYC oxidative products on cell viability, oxidation status,
ROS generation, their impact on cell cycle progression and
apoptosis. Initially, the effect of LYC on cytotoxicity of various
cancer cell lines (PC-3, MCF-7, A431, HepG2, HeLa and A549) was
evaluated. Based on this, cell lines PC-3, MCF-7 and HeLa with
maximum growth inhibition by LYC were chosen to understand the
role of LYC oxidation products, expecting that outcome of the study
will have the potential to treat cancer and other health associated
problems.
2. Materials and methods
2.1. Materials
(all-E)-Lycopene (>90%), Propidium iodide, toluene, potassium
permanganate, Poly-D-lysine, ethidium bromide, acridine orange,
dichloro-dihydro-ﬂuorescein diacetate (DCHF-DA) dye, 4,6-
diamidino-2-phenylindole dilactate (DAPI) and butylated hydrox-
ytoluene (BHT), tetrahydrofuran (stabilized with BHT) were pur-
chased from Sigma-Aldrich (St Louis, MO, USA). Glutathione,
glutathione reductase, 5, 5-dithiobis (2-nitrobenzoic acid) (DTNB),
NADPH, EDTA were purchased from Sisco Research Laboratories
(Mumbai, India). Acetone, hexane, methanol, acetonitrile and
tetrahydrofuran of HPLC- grade solvents, PVDF syringe ﬁlters
(0.45 mm) were procured from Merck (Mumbai, India). Dulbecco's
minimal essential medium (DMEM), Minimum essential medium
(MEM), Ham's F-12 media, fetal bovine serum (FBS), 3-(4, 5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT),
antibiotic antimycotic solution, calciummagnesium free phosphate
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chased from Hi-Media Chemical Laboratories (Mumbai, India). FITC
Annexin-V apoptosis detection kit was purchased from BD phar-
mingen (BD Bioscience, San Diego, CA). All other chemicals and
solvents of analytical grades were purchased from Sisco Research
Laboratories (Mumbai, India).
2.2. Isolation of lycopene from the tomato
LYC was extracted from ripened stage tomatoes (Indian hybrid)
as per our method Arathi et al. (2015a). The peak identity, ab-
sorption maxima (l max), and characteristics UVeVisible spectra of
LYC was conﬁrmed by UPLC-PDA-MS (APCIþve). Extraction and
preparation of LYC samples and standards were carried out under
dim yellow light at 4 C to prevent isomerization and degradation.
2.3. Preparation of lycopene autoxidation products
For autoxidation mixtures (AOL), LYC (5 mg/5 mL) was dissolved
in toluene and incubated in a water bath at 37 C for 24 h under
atmospheric oxygen condition with regular shaking (100 rpm). The
autoxidised products of LYC were extracted as per the established
method (Arathi et al., 2015a) and veriﬁed by using characteristic
absorption spectra obtained by UPLC (Emenhiser et al., 1995).
2.4. UPLC-MS conditions for LYC and AOL analysis
Qualitative analysis of LYC and AOL was done by using Waters
Xevo TQD mass spectrometer interfaced with the ACQUITY UPLC®
systemvia an APCI source operated in positive ionmode. An aliquot
(2 mL) of LYC sample containing ~40 mg/mL was injected onto the
CSH Phenyl-hexyl column (100  2.1 mm; 1.7 mm). Mobile phase
contained 10mM ammonium acetate in Milli-Q water (A) and 5% of
THF in acetonitrile (B) with the ﬂow rate of 0.4 mL/min and was
monitored at 471 nm by using PDA detector. The gradient condition
of mobile phase was maintained as follows: 25% of A and 75% of B
solvents was ﬁxed initially, then increased solvent B to 85% in
3 min, 90% in 8 min and returned to 75% in 8.2 min. Mass spec-
trometry was conditioned by following parameters: corona voltage
0.9 kV, cone 35 V, RF 2.50 V, extractor 3.00 V, source temperature
150 C, probe temperature 450 C, cone gas ﬂow 50 L/hour, des-
olvation gas ﬂow 900 L/hour. Mass spectra of LYC and AOL were
acquired with an m/z 0e1000 scan range. The MS identity of
standard (all-E)-LYC was compared with the puriﬁed LYC sample.
Data were processed with Mass Lynx 4.1 software (Waters, USA).
2.5. Lycopene oxidation by KMnO4
LYC was subjected to oxidation by using KMnO4 as per the
procedure of Catherine Caris-Veyrat et al. (2003) with slight
modiﬁcation. In brief, LYC (30 mg) and cetyltrimethylammonium
bromide (6 mg) were dissolved in 30 mL DCM/toluene (1:1 ratio)
and made 6 aliquots (5 mg/5 mL) separately for degradation study.
The oxidation of LYC was initiated by adding 1.5 mL of aqueous
solution of KMnO4 stock (135 mg in 9 mL water) to the LYC sample.
The reaction mixture was stirred on a magnetic stirrer and incu-
bated for different time points (5, 10, 15, 20, 30 & 40 min) at room
temperature (26 ± 2 C). Then, separation of the organic phase was
done by repeated washing with double distilled water (10 mL). The
organic solvent phase of LYC oxidised sample was ﬁltered through a
PVDF ﬁlter (0.45 mm) and dried on sodium sulphate under nitrogen
environment. The residue of LYC oxidised mixture was re-dissolved
in petroleum ether and ﬁltered againwith PVDF ﬁlter to remove the
KMnO4 remnant. Oxidative products obtainedwere analysed byMS
- APCI þve mode. The degradation time point ODT100 anddegradation half ODT50 of LYC incubated with KMnO4 was calcu-
lated, and the optimal ODT50 was preferred for further cell culture
treatments. The aliquots of LYC and its oxidative products were
sealed under nitrogen environment and used for cell culture
treatments or stored in -80 C in amber vials.
2.6. MS conditions and analysis of lycopene oxidation products
MS analysis of LYC and COL products was performed on the
Thermo Scientiﬁc, LC-MS system coupled to an Ion Trap mass
spectrometer (LCQ Deca XP Max). The capillary and vaporizer
temperatures were set at 298 C and 300 C. The corona discharge
current was (5 mA), Entrance lens (34.6 V) and nitrogenwas used as
a sheath and drying gas at 18.85 and 58.89 L/min and ion gaugewas
0.76  10e5 Torr. The spectrometer was calibrated in the positive
ion mode. Mass spectra of LYC and its oxidised products were ac-
quired with an m/z 0e700 scan range. Due to unavailability of
reference standards for LYC oxidative products and constraint in the
sample size, the possible structure of COL products were predicted
and characterized using Chemsketch 8.0 software (ACD Labs, USA).
2.7. Cell biological assays used to assess toxicity and apoptosis
inducing activity
2.7.1. Cell lines and culture conditions
Cancer cell lines (PC-3, MCF-7, A431, HepG2, HeLa and A549)
were purchased from National Centre for Cell Science, Pune, India.
Cells were grown in DMEM, MEM or Ham's F-12 media, containing
10% FBS (GIBCO BRL, USA), 4 mM L-glutamine, and antibiotics
(40 mg/mL penicillin and 40 U/mL streptomycin) at 37 C in a hu-
midiﬁed atmosphere of 5% CO2 in the air.
2.7.2. Cell viability assay
Exponentially growing cells (70e80%) were seeded
(5 103 cells/well) in the 96-well plate containing 200 mL of culture
medium. After 24 h of incubation, media was removed and
replenished with 200 mL of the media containing puriﬁed LYC
(1e50 mM) dissolved in THF (0.5%) and incubated for 48 h (Kotake-
Nara et al., 2001). Based on the effect of LYC, three cell lines (PC-3,
MCF-7 and HeLa) with maximum reduction in cell viability were
chosen for further experimentation. Cells treated separately either
with LYC (50 mM), or its equivalent relative concentration of AOL or
COL or without carotenoid (control) were incubated for 24 h. The
reason for selection of higher concentration of LYC for cell treat-
ment was, LYC may lead to generation of cleavage products at a
lower concentration with lesser stability. These compounds are
reported to decompose quickly than the major fragments
(Lakshminarayana et al., 2013). The ﬁnal concentration of THF in
the culture medium was 0.5%, and control culture received a same
concentration of THF alone. Then, the inﬂuence of LYC oxidation
products on cell viability was evaluated as described above. Further,
to support the effect of LYC, AOL and COL on cell death was deter-
mined by trypan blue dye exclusion assay (Palozza et al., 2002). In
brief, cells were cultured (1  105 cells/mL) and treated with
increasing concentrations (1, 5, 10, 25 and 50 mM) of LYC, AOL and
COL and incubated for 24 h. Then cells were trypsinized, collected
and the number of viable cells and dead cells were determined by
trypan blue staining (0.4%) using haemocytometer. Experiments
were repeated three times independently (data not shown).
2.7.3. Measurement of glutathione and malondialdehyde (MDA)
levels in cells
A standard solution of glutathione, as well as cell lysates from
control and cells treated with LYC, AOL or COL were incubated with
the solution containing NADPH (12 mM), 0.1 mM DTNB and 50 U/L
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100 mM sodium-phosphate buffer with 5 mM sodium EDTA (pH
7.4). Oxidised glutathione is reduced by NADPH in the presence of
GR and sequentially oxidised by DTNB. The rate of 5-thio-2-
nitrobenzoic acid formation was measured at 412 nm and gluta-
thione levels (nmoles/mg protein) present in the sample were
recorded by using a standard curve (Tietze, 1969). For lipid perox-
ides estimation (nmoles MDA/mg protein), cells were trypsinized
and the pellets were lysed using tris-buffer (50mM), EDTA (15mM)
with the protease inhibitor. The cell lysate was used to measure
MDA (Ohkawa et al., 1979). Protein was estimated according to
Lowry's method (Lowry et al., 1951).
2.7.4. Cell cycle analysis
Cell cycle analysis was done by ﬂow cytometry Sowmya et al.
(2015). In brief, control and treated cells (1  105 cells/well in 12
well plate) after 24 h incubationwere rinsedwith PBS and detached
with trypsin- EDTA at room temperature and centrifuged at
2500 rpm for 5 min. The cells were washed twice with PBS and
resuspended in 1 mL ice-cold hypotonic solution, containing 0.1%
triton X-100, 0.1% citrate buffer and 0.1 mg/mL RNase and 50 mg/mL
propidium iodide and incubated for 15 min at 37 C in the dark.
After incubation, the cell suspension was analysed for the relative
proportions of cells with DNA content diploid G0eG1 (2n), S phase
(>2n but <4n), G2/M phase (4n) and sub-G1 peak (sub-diploid
cells). The cell cycle distribution were measured with FACS verse
ﬂow cytometer (BD Biosciences, San Jose, CA, USA) and analysed by
FACS Diva Analysis software.
2.7.5. Apoptosis detection
Apoptosis detection was made with an FITC Annexin-V
apoptosis detection kit according to the manufacturer's in-
structions. Brieﬂy, control and treated cells (1  105 cells/well in 12
well plate) after 24 h of incubationwere collected, washedwith ice-
cold PBS and centrifuged at 2500 rpm for 5 min. The cell pellet was
resuspended in the ice-cold 1X binding buffer and incubated with
FITC-conjugated Annexin V and Propidium iodide (PI) for 15 min at
room temperature in the dark. Prior to the analysis, the instrument
was calibrated with internal controls, such as unstained cells
(negative control) and stained cells (annexin-FITC, PI and annexin-
FITC with PI control cells), respectively. The samples were imme-
diately analysed on FACS verse ﬂow cytometer using the Diva
analysis software.
2.7.6. ROS detection by ﬂow cytometry
Control and treated cells (2  105) were harvested after 24 h of
incubation, washed with PBS, and suspended in 1 mL PBS. Followed
by DCFH-DA (10 mM)was added and incubated for 15min in 5% CO2
at 37 C. After incubation, cells were washed and resuspended in
PBS and were analysed within 1 h on FACS Verse Flow Cytometer.
Each cell typewas analysed by ﬂow cytometry after calibrationwith
negative (unstained) and positive control (H2O2) cells. The results
were expressed as ﬂuorescence intensity of dichloroﬂuorescein
compared with control, treatment and cells with H2O2 (positive
control).
2.7.7. Fluorescence morphological examination by AO/EB and DAPI
The cellular morphological changes were studied by using
ﬂuorescence microscope (CKX 41, Olympus Inverted Trinocular
Fluorescence Microscope, Japan). Cells were seeded (50,000 cells/
100 ml) onto a poly-D lysine coated cover slips and cultured to about
75% conﬂuency. Cells with and without COL was incubated for
24 h at 37 C and 5% CO2, dual stained with 1:1 ratio of acridine
orange (100 mg/mL) and ethidium bromide (100 mg/mL) for 5 min.
For further conﬁrmation, nuclei staining were done with 1 mg/mLDAPI for 3 min in the dark. The cells were then washed with PBS
three times. The morphology of cell nuclei was observed and im-
ages were documented using Q-Imaging MP3.3 cooled colour
camera with Q-Capture Pro7 imaging software (Canada).
2.8. Statistical analysis
Data were tested for homogeneity of variances by the Bartlett
test. When homogenous variances were conﬁrmed, the data were
tested by ANOVA and signiﬁcant differences between the groups
were evaluated by Tukey's test. The difference in mean was
considered signiﬁcant at p < 0.05.
3. Results
3.1. Isolation and characterization of LYC, and its possible oxidation
products
LYC isolated from ripened tomato puree was compared with
analytical standard and conﬁrmed its characteristic UV-spectra, l-
max, retention time andmass spectra. The LYC content in the tomato
puree was 9.01 ± 0.65 mg/100 g wet weight and the purity of
isolated LYC was found to be 93 ± 5% as per the UPLC analysis as
indicated in Fig. 1. The autoxidation of LYC resulted in isomerization
and there was no degradation has observed previously (Arathi
et al., 2015a). Further, LYC (5 mg/5 mL) was oxidised with KMnO4
incubation, and the optical density of the sample was measured.
The results showed that after incubation, LYC concentration
depleted with increased duration of exposure time, indicating
degradation of LYC, follows ﬁrst-order degradation whereas, LYC
has followed a zero-order degradation kinetics (Fig. 2). An initial (0-
min exposure) LYC concentration (5 mg/mL) was measured at
470 nm which decreased to less than 0.5 mg/5 mL after 40 min
exposure, indicating that LYC was involved in a chemical reaction
with KMnO4 or radicals generated from it (Fig. 2a), which resulted
in a change in its chemical structure (spectral change) (Fig. 2b). The
LYC was readily oxidised to form the mixture of oxidative products,
the degradation was due to break in its conjugated double bond in
the polyene chain. The oxidised or break down products can be
formed either primary or secondary reactions. The characteristic
UVevisible spectra lend further support to the hypothesis that LYC
is degraded to various oxidative products either with single or
multiple step reactions (Figs. 2 and 3). The possible characteristic
fragmented ions, formed from LYC in the samples exposed to
KMnO4 are shown in Table 2. The residual LYC after 16 min of in-
cubation with KMnO4 was 50% remaining 50% was oxidised under
described conditions, were further used for cell culture studies. The
MS proﬁle of LYC oxidation products are shown in Fig. 3. The MS
analysis of negative control (without LYC) showed no cross
contamination of KMnO4 and showed only base line peak.
3.2. Effect of lycopene on cell viability
The effect of LYC on cell viability of different cancer cell lines was
shown in Fig. 4. LYC (1e50 mM) inhibited the cell growth dose-
dependently (up to 5 mM) when compared to respective controls.
The cell viability of all the cancer cell lines treated with 5 mM LYC
was signiﬁcantly different (p < 0.05) when incubated for 48 h. It
was observed that there is no signiﬁcant difference in cell number
between untreated and vehicle control. Result suggest that THF
(0.5%) stabilized with BHT did not affect the cell growth. However,
upon LYC treatment, the percent cell viability in different cancer
cell lines was observed in the order of PC-3 (47.3%) < HeLa
(33.7%) < MCF-7 (29.8%) < A549 (27.3%) < HepG2 (22.9%) < A431
(17.8%). Among cancer cell lines, a signiﬁcant reduction in cell
Fig. 1. A typical UPLC proﬁle and UV spectra (a) MS analysis of puriﬁed lycopene (b).
Fig. 2. KMnO4 induced degradation pattern of lycopene at different time points (a) and their overlaid UV absorbance spectra (b). Values are mean ± SD of three samples.
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tested cell cytotoxicity of LYC was lower in HepG2 and A431 cells.
These data demonstrate that the effect of LYC on cell viability was
mostly dependent on cell type and dosage. Hence, these cell lines
were treated further to evaluate the inﬂuence of LYC oxidative
products on ROS generation and induction of apoptosis.3.3. Effect of LYC oxidative products on cell viability
The inﬂuence of LYC and LYC oxidative products (AOL or COL) on
cytotoxicity of PC-3, HeLa andMCF-7 cells were shown in Fig. 5. The
COL strongly inhibited the cell viability compared to AOL and LYC.
The % cell viability of PC-3 cells were decreased by 29.6 (LYC), 39.2
(AOL) and 71.4% (COL) compared to control. Likewise, 29.3, 44.2 &
68.4% decrease in MCF-7 and 32.6, 29.4 & 56.2% decrease in HeLa
cells was evident compared to control respectively (Fig. 5). Inaddition to this, cell death was measured by tryphan blue dye
exclusion that strongly conﬁrmed the above results (data not
shown). The IC50 concentration of COL was found to be 35.0, 36.5,
44.4 mM respectively in PC-3, MCF-7 and HeLa cells.3.4. Oxidation status of LYC, AOL and COL treated cells
Results of glutathione levels in PC-3 cell lines was lower by 15.5
(LYC), 9.7 (AOL) and 49.5% (COL) respectively than control (Fig. 6). It
is evident that the glutathione levels in, LYC oxidative products
treated culture decreased signiﬁcantly by 34 and 39.8% in COL than
LYC and AOL indicating that COL is superior to LYC and AOL. The
effect of LYC and LYC oxidised products on GSH levels in MCF-7 cells
were shown in Fig. 6. Glutathione levels of control cells were higher
by 30.4, 36.0 and 50.4% than LYC, AOL and COL, respectively.
Similarly, in the case of HeLa cells, the levels of GSH in control cells
Fig. 3. APCIþve - Mass Spectra proﬁle of KMnO4 induced LYC oxidised products. Refer Table.1 for respective molecular mass and possible structures of A-H (NI-Not identiﬁed).
Fig. 4. Effect of lycopene (1e50 mM) on viability of different cancer cell lines. Cells
were treated with various concentrations of lycopene for 48 h a,b,c,d Values not sharing
common letters are signiﬁcantly different (p < 0.05) between cell lines as determined
by two-way ANOVA followed by Tukey's test. Values are mean ± SD of ﬁve samples.
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Fig. 5. Effect of LYC, AOL and COL on the viability of MCF-7, PC-3 and HeLa cell lines
treated for 24 h a,b,c,d Values not sharing common letters are signiﬁcantly different
(p < 0.05) between treated and control samples as determined by two-way ANOVA
followed by Tukey's test. Values are mean ± SD of ﬁve samples.
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respectively.
Correspondingly, the inﬂuence of LYC oxidised products on lipid
peroxides (MDA) level in treated cells was shown in Fig. 6. TheMDAFig. 6. Inﬂuence of LYC, AOL and COL on glutathione (a) and MDA (b) levels in MCF-7,
PC-3 and HeLa cells treated for 24 h a,b,c Values not sharing common letters are
signiﬁcantly different (p < 0.05) between treated and control samples as determined
by two-way ANOVA followed by Tukey's test. Values are mean ± SD of ﬁve samples.
Table 1
Inﬂuence of LYC and COL on cell cycle progression and apoptosis in MCF-7, PC-3 and HeLa cell lines.
Experimental groups Cell cycle distribution (%) Apoptosis (%) (EA þ LA)*
Sub G1 G0/G1 S G2/M
MCF-7 cells
Control 2.1 ± 1.2a 72.6 ± 1.5a 11.6 ± 1.2a 13.8 ± 1.9a 9.9 ± 1.9a
LYC 1.9 ± 1.8a 73.7 ± 0.5a 10.5 ± 0.4a 13.5 ± 1.6a 12.2 ± 1.3a
COL 18.5 ± 2.1b 53.5 ± 0.8b 13.5 ± 1.4b 15.0 ± 1.4a 31.1 ± 1.7b
PC-3 cells
Control 0.9 ± 0.4a 71.3 ± 0.5a 12.6 ± 0.7a 14.6 ± 1.8a 5.1 ± 1.3a
LYC 1.2 ± 1.2a 72.4 ± 0.8a 12.5 ± 0.5a 13.5 ± 1.6a 8.1 ± 1.8b
COL 15.5 ± 1.5b 57.9 ± 0.4b 12.6 ± 0.7a 14.0 ± 0.7a 22.0 ± 1.5c
HeLa cells
Control 1.2 ± 1.8a 72.0 ± 1.3a 12.1 ± 0.7a 14.2 ± 1.5a 10.1 ± 1.3a
LYC 1.8 ± 1.2a 73.3 ± 0.8a 12.8 ± 1.2a 12.1 ± 1.4a 9.7 ± 1.9a
COL 12.5 ± 1.2b 59.8 ± 2.5b 13.6 ± 0.9b 14.1 ± 0.9a 21.8 ± 1.5b
The values are mean ± SD (n ¼ 3).
*EA-Early apoptosis, LA-Late apoptosis.
a,b,c Values not sharing a common superscript letters within a column under each type of cells treatment are signiﬁcantly different (p < 0.05) from their respective control
samples, as determined by one-way ANOVA followed by Tukey's test.
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30.3, 39.7 and 36.2% than control, LYC and AOL. Likewise, MDA
levels in MCF-7 cells treated with COL was higher by 20.4, 33.0 and
30.2% than control, LYC and AOL. In the case of HeLa cells, COL
treated cells shown higher levels of MDA formation by 14.2, 33.5
and 25.8% than control, LYC and AOL, respectively (Fig. 6).
3.5. Apoptosis induction of lycopene oxidation products
Based on the results of cytotoxicity and oxidative status, it was
observed that there is no signiﬁcant difference between AOL and
LYC. Hence, hereafter COL was used for further experimentation toFig. 7. Detection of apoptosis in MCF-7, PC-3 and HeLa cells treated with LYC and COL produ
each panel, Q4 quadrant shows annexin V positive cells which are in early stage of apoptosis
shows PI positive cells which are dead. Bar diagram represents the distribution of early, latevaluate its efﬁciency against anti-proliferation of cancer cell lines.
Cell cycle analysis was carried out in control and cells treated with
LYC (50 mM) or its relative concentration of COL for 24 h. An increase
in apoptosis was observed in PC-3, MCF-7 and HeLa cells treated
with COL (Table 1). Further, FACS analysis demonstrated that COL
treated cells showed an increase in Sub-G1 peak representing the
apoptotic cell population. The inﬂuence of COL on apoptosis was
conﬁrmed further by Annexin FITC-PI staining and shown in Fig. 7
and Table 1. Results of ﬂuorescence microscopic observation
showed an early and late apoptosis, morphological changes and
nuclear condensations in COL treated cells (Fig. 9). The live cells
were stained uniformly green, early apoptotic cells were greenwithcts. Cells were stained with annexin V-FITC and PI, and analysed by ﬂow cytometry. In
, Q2 shows both annexin V and PI positive, which are in the late stage of apoptosis, Q1
e and necrotic cell populations. Values are mean ± SD of three samples.
Fig. 8. Flow cytometry analysis showing levels of intracellular ROS generation in MCF-7, PC-3 and HeLa cells treated with LYC and COL using DCFH-DA assay. Values are mean ± SD
of three samples.
B.P. Arathi et al. / Food and Chemical Toxicology 97 (2016) 265e276272bright green nuclei due to chromatin condensation and nuclear
fragmentation. Late apoptotic cells were stained orange with nu-
clear condensation.
3.6. Intracellular ROS generation
Inﬂuence of LYC and its oxidation products (COL) on the levels of
intracellular ROS in three different cell lines were shown in Fig. 8. In
all the cases, COL increased the ROS levels than the LYC and control
treated cells. In the case of MCF-7 cells, the levels of ROS in control
and LYC were lower by 16.3 and 15.5% than COL treated cells. This
may be the reason for higher cell death in COL treated cells. Simi-
larly, in PC-3 cells, the ROS levels were lowered by 13.6% in control
and 10.7% in LYC compared to COL. In case of HeLa cells, ROS levels
were lower by 12.8% in control and 8.2% in LYC than the COL treated
cells respectively. The % of ROS in positive control was found to be
43.2, 65.0 and 53.6% in MCF-7, PC-3 and HeLa cells, respectively.
4. Discussion
Possible biological functions of carotenoid oxidative products or
metabolites are currently an active area of investigation in nutrition
and biomedical research. Recent advancement in carotenoid
metabolism necessitated to hypothesize that, carotenoid metabo-
lites/oxidative products are responsible for bioactivity (Arathi et al.,
2015b). Several carotenoid metabolites including LYC have been
identiﬁed in vitro and in vivo (Khachik et al., 1997; Kim et al., 2001;
Caris-Veyrat et al., 2003; Hu et al., 2006; Kopec et al., 2010; Nidhi
et al., 2015). In this study, we identiﬁed and elucidated possible LYC
oxidative products induced by KMnO4. The fragmented ion lyco-
pene 1, 2 epoxide (designated as compound B) detected in this
study may also be formed in vivo due to metabolic oxidation of LYC
(Rodriguez and Rodriguez-Amaya, 2009). The similar compound
was also formed by oxidation when LYC incubated with m-chlor-
operbenzoic acid (Rodriguez and Rodriguez-Amaya, 2009). Previ-
ously, Caris-Veyrat et al. (2003) have characterized LYC oxidation
products in vitro by KMnO4 and atmospheric oxygen catalyzed by
metalloporphyrin. They have postulated the formation of LYC me-
tabolites (apo-lycopenal, apo-lycopenone and apo-carotendials)
in vivo. Further, ionization and mass of respected fragmentedions can vary under optimization of mass spectrometer conditions
(Sowmya et al., 2014). Correspondingly, Pennathur et al. (2010)
identiﬁed HOCl-mediated oxidative products of LYC (apo-lycope-
nal, apo-lycopenic acid and apo-carotendials) and proposed the
cleavage pattern. We also found few similar LYC oxidation products
(C, D, E, and H) as they reported earlier (Table 2). Compound F and G
were found to be newmolecules and designated as (4E, 6E, 8E, 10E,
12E, 14E)-2, 7, 11, 15, 19-pentam ethylicosa-2, 4, 6, 8, 10, 12, 14, 18-
octaene and (2E, 4E, 6E, 8E, 10E,12E,14E,16E)-2, 6, 11,15-
tetramethyloctadeca-2, 4, 6, 8,10,12, 14, 16-octaenedial. The
detailed characterization of these compounds could not be carried
out due to quantitative limitations and stability issues. Since not
many studies are available on the biofunctionality of oxidation
products of LYC and being similar kind of molecules reported in the
biological system (Kopec et al., 2010). We limited our studies with
MS analysis and composite oxidised LYC products for evaluation of
their functions.
The cytotoxic studies demonstrated that LYC is comparatively
effective at > 5 mM in various cancer cell lines studies (Fig. 4). The
varied percent cytotoxicity of LYC in different cancer cell lines may
be due to the difference in cell growth modality, cell metabolic
status, membrane composition and level of carotenoid accumula-
tion (Sowmya et al., 2015). Earlier, Teodoro et al. (2012) shown a
signiﬁcant decrease in number of viable cells after LYC treatment
for 48 h inHT-29, T84 cells and MCF-7 cell lines among eight
different cancer cell lines (HT-29, T84, MCF-7, DU145, A549, Hep-
G2, HeLa and Hep2). In addition, they also observed discreet ef-
fect of LYC at 5 mM in DU 145 and HeLa cells, and no effect was found
in the other cells. Furthermore, they concluded effect of lycopene
on anti-proliferation of cancer cells may be due to cellular type,
time and dose.
Likewise, in the present study we observed signiﬁcantly
decreased cell viability in MCF-7, PC-3, and HeLa cell lines. The
variable results of cell viability compared to others report Teodoro
et al. (2012) may be attributed due to lycopene source or mode of
delivery used for the experiment. The source of LYC used by Teo-
doro et al. was commercially obtained whereas in this study it was
puriﬁed from tomato source. In continuation, Soares et al. (2014)
evaluated role of lycopene on induction of apoptosis in human
prostate cancer (PCa) cells and observed the up-regulation of Bax
Fig. 9. Morphological observation of COL treated MCF-7, PC-3 and HeLa cells with acridine orange/ethidium bromide staining, (200x) arrows indicate early and late apoptotic cells.
DAPI was used as a nuclear marker. Note: The microscopic ﬁeld for AO/EB and DAPI are different with the same cell lineages.
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have correlated the effect of LYC in the reduction of prostate cancer
(Kim et al., 2002; Etminan et al., 2004; Gunasekera et al., 2007;
Ivanov et al., 2007). The results obtained may be partly due to the
metabolites/oxidation products of LYC. However, studies related to
role of metabolites/oxidation products on molecular mechanism
such as cyclins and the inhibitor of apoptosis proteins (IAPs), needs
to be addressed. In contrast, few reports have shown the limited
effect of LYC in prostate and other cell lines (Forbes et al., 2003;
Burgess et al., 2008). These studies show that effect of LYC was
found to be highly variable may be due to variations of in vitro
techniques, cell types, culture conditions, stability and solubility of
LYC in cell culture systems that make it very difﬁcult to understand
the mechanism of action (Ford et al., 2011). As observed in previous
study (Lakshminarayana et al., 2010), here we have noticed con-
centration of LYC studied and LYC oxidation products did not affectthe normal cells under the experimental conditions. Further, the
effect of LYC oxidation products on anti-proliferation of different
cancer cell lines are less explored. Although the higher concentra-
tion of LYC has not shown a detrimental effect on cell viability than
5 mM in all the three cell lines, the higher concentration of LYC was
used for cell treatment, since oxidation of carotenoid may lead to
the generation of smaller fragments with lower concentration and
lesser stability (Lakshminarayana et al., 2013). We identiﬁed and
interpreted for the ﬁrst time that COL products exhibited higher
anticancer property on MCF-7, PC-3 and HeLa cell lines. The cyto-
toxic effect of COL was found to be more pronounced which may be
due to change in its polarity than the intact LYC. It was observed
that LYC and AOL had minimal effect since they are hydrophobic in
nature and forms aggregation. Earlier, Hu et al. (1998) identiﬁed 5,
8-Endoperoxy-2, 3-dihydro-b-apocarotene-13-one an oxidation
product of b-carotene and shown its growth inhibition of breast
Table 2
Fragmented ions derived from LYC after incubation with KMnO4, elucidated by MS APCI þve mode showing their possible molecular structure, molecular mass and molecular
formula.
Alphabet m/z Proposed structure Formula App. Mol. Wt. Name
A 537.44 C40H56 536.43 Lycopene
B 553.4 C40 H56O 552.4 2,2-dimethyl-3-(3E, 5E, 7E, 9E, 11E,
13E, 15E, 17E, 19E, 21E, 23E) -3,7, 11,
16, 20, 24, 28 e heptamethylnonacosa -3,
5, 7, 9, 11, 13, 15, 17, 19, 21, 23,
27-dodecaenyl) oxirane
C 449.2 C29H36O4 448.59 (2E, 4E, 6E, 8E,10E, 12E, 14E, 16E, 18E, 20E)-4,
8, 13, 17, 21 e pentamethyltetracosa -2, 4, 6, 8,
10, 12, 14, 16, 18, 20-decaenedioic acid
D 391.2 C27H34O2 390.2 Apo-1,60-carotendial
E 349.2 C24H28O2 348.2 Apo-5,60-carotendial
F 340.4 C22H28O3 339.2 (2E, 4E, 6E, 8E, 10E, 12E, 14E)-17-formyl-2, 7, 11,
15-tetramethylheptadeca-2, 4, 6, 8, 10, 12,
14-heptaenoic acid
G 323.1 C22H26O2 322.1 (2E, 4E, 6E, 8E, 10E,12E,14E,16E)-2, 6, 11,
15-tetram ethyloctadeca-2, 4, 6, 8, 10, 12,
14, 16-octaenedial
H 285.2 C20H28O 284.2 (2E, 4E, 6E, 8E, 10E) - 3, 7, 11, 15
-tetramethylhexadeca - 2, 4, 6, 8, 10, 14 -hexanal
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greater differentiation inducing activity than b-carotene in
leukaemia cells (Duitsman et al., 1999). Hanusch et al. (1995) have
reported an oxidation product (4-oxo-retinoic acid) of canthaxan-
thin activates retinoic acid receptor-b gene and enhance gap
junctional communication in murine ﬁbroblast cells. In the current
study, we observed the accumulation of cells at sub-G1 peak in COL
treated cell lines during cell cycle regulation. Further, cell death by
apoptosis was shown with an increase in both early and late
apoptotic populations compared to control and LYC (Table 1 andFig. 10. Scheme of redox status and proposed therapeutic approach on cytotoxic effect of ly
cells.Fig. 7). Previously, Nara et al. (2001) have showed the involvement
of acyclic carotenoid oxidation products on cancer cell growth in-
hibition. Likewise, Zhang et al. (2003) demonstrated the role of LYC
cleavage product, (E, E, E)-4 methyl-8-oxo-2, 4, 6-nonatrienal on
induction of apoptosis through down regulation of Bcl-2 and Bcl-XL
expression in HL-60 cells. While, Aust et al. (2003) shown the
implication of LYC oxidation product (2, 7, 11-trimethyl-tetradeca-
hexaene-1, 14 dial) on cell signalling via gap junctions in WB-
F344 cells. Here, COL treated MCF-7, PC-3, HeLa cells showed
increased apoptosis with 3.1, 4.3, 2.1 fold than control, likewise 2.4,copene cleavage products by modulation of ROS and programmed cell death in cancer
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tively. The higher percent of apoptosis found in this study was
presumed due to an increased oxidative status of cancer cells as
shown by higher cellular levels of MDA and depleted glutathione in
COL treated cells than control and LYC (Fig. 6). The depletion of
glutathione and increases in MDA levels, reﬂects lipid peroxidation
within mitochondria, indicating an increase in oxidative stress
(Siems et al., 2002). Further, the elevated accumulation of reactive
oxygen species induces oxidative damage to proteins, including the
adenine nucleotide translocator, lipids, and DNA molecules in sub-
cellular organelle like mitochondria, and nucleus (Siems et al.,
2002). Carotenoids are known to act as radical scavengers and
have been noted relevant use to modulate altered physiology or
biochemical changes in complications like cancer. In contrast, ca-
rotenoids are shown to behave as pro-oxidant under certain situ-
ations in vitro and in vivo. The antioxidant/pro-oxidant properties
of carotenoids are complex and can vary with the chemical envi-
ronment and nature of carotenoid species (El-Agamey et al., 2004).
Possibly, peroxyl radicals (ROO) can covalently add to the carot-
enoid molecule forming an adduct (ROOCAR) or peroxyl radical
can abstract a hydrogen atom from the carotenoid to form a
carotenoid radical (CAR) (Prasad et al., 2006). Further, carotenoid
also transfers an electron to the peroxyl radical, so that the carot-
enoid becomes a radical cation (CARþ) and these radicals can react
further in various ways. Previously, we revealed the presence of
shorter polyene chain cleavage products from lutein derived from
either photo or UV oxidation react with peroxy radicals through a
number of reaction mechanisms (Lakshminarayana et al., 2008,
2013; Nidhi et al., 2015). In the present study, the induction of
apoptosis by COL may positively correlate with intermediate pro-
duction of intracellular ROS than lycopene treated and vehicle
control cells (Fig. 8). Further, in agreement with previous report
Prasad et al. (2006), we hypothesized that ROS generation and
levels may profoundly alter the pro-apoptotic proteins and induce
apoptosis (data not shown). Studies also have shown that b-caro-
tene at higher concentration acts as pro-oxidants and induce
apoptosis by increasing intracellular ROS levels (Palozza et al.,
2001; Cui et al., 2007). Previously, Siems et al. (2002) reported
that b-carotene cleavage products are involved in carcinogenic ef-
fect by impairing mitochondrial functions under high oxidation
stress in rat and also proposed the mechanism of pro-oxidant effect
of b-carotene. In addition, microscopic observations of COL treated
cell lines in this study conﬁrmed the apoptosis by typical
morphological changes in cells and DNA condensation (Fig. 9).
These results suggest that oxidation products of LYC may have a
signiﬁcant role against cancer cells proliferation. As per our
knowledge and available literature there is no information related
to the concentration of carotenoids oxidation products on biolog-
ical functions. Based on current observation, we proposed the
therapeutic approach of LYC oxidation products and their possible
mechanism on progression of cytotoxicity and cell death in cancer
cells (Fig. 10). Further, isolation, separation and characterization of
individual oxidation product is required to determine its chemical
and biological properties (under standardization).
To conclude, there are several unknown metabolites or oxida-
tion products of LYC, apart from the major ones, that may be
involved in the reduction of cell proliferation, through modulating
cell cycle progression. In this study, we have demonstrated that the
COL products are potent in the induction of apoptosis with inter-
mediate ROS generation than intact LYC and AOL. The effect of COL
could be synergistic or due to the presence of individual bioactive
fragmented compounds of LYC. These results suggested that
oxidation products of carotenoids may attribute potential health
beneﬁts. Further, detailed characterization and stability of these
oxidation products in a biological environment is challenging anddeserves future studies to understand speciﬁc biological function.
Acknowledgments
Mrs Arathi B.P. acknowledges Department of Science and
Technology, Govt. of India. for the grant of Women Scientist
Fellowship (F.NO.SR/WOS-A/LS-35/2012). Authors acknowledge
the Department of Biotechnology-Bangalore University, UGC-SAP
and DST-FIST facilities. Authors also acknowledge Indian Institute
of Science for FACS facilities, and Professor T. Ramasharma and Dr.
D. Lakshmanan for critical review of the manuscript with respect to
subject and English language.
Transparency document
Transparency document related to this article can be found
online at http://dx.doi.org/10.1016/j.fct.2016.09.016
References
Arathi, B.P., Sowmya, P.R., Vijay, K., Baskaran, V., Lakshminarayana, R., 2015a.
Metabolomics of carotenoids: the challenges and prospects e a review. Trends
Food Sci. Tech. 45, 105e117.
Arathi, B.P., Sowmya, P.R., Vijay, K., Dilshad, P., Saikat, B., Gopal, V.,
Lakshminarayana, R., 2015b. An improved method of UPLC-PDA-MS/MS anal-
ysis of lycopene isomers. Food Anal. Methods 8, 1962e1969.
Aust, O., Ale-Agha, N., Zhang, L., Wollersen, H., Sies, H., Stahl, W., 2003. Lycopene
oxidation product enhances gap junctional communication. Food Chem. Tox-
icol. 41, 1399e1407.
Burgess, L.C., Rice, E., Fischer, T., Seekins, J.R., Burgess, T.P., Sticka, S.J., Klatt, K., 2008.
Lycopene has limited effect on cell proliferation in only two of seven human cell
lines (both cancerous and noncancerous) in an in vitro systemwith doses across
the physiological range. Toxicol. vitro 22, 1297e1300.
Burton, G.W., Ingold, K.U., 1984. b-Carotene: an unusual type of lipid antioxidant.
Science. 224, 569e573.
Caris-Veyrat, C., Schmid, A., Carail, M., B€ohm, V., 2003. Cleavage products of lyco-
pene produced by in vitro oxidations: characterization and mechanisms of
formation. J. Agric. Food Chem. 51, 7318e7325.
Cui, Y., Lu, Z., Bai, L., Shi, Z., Zhao, W.E., Zhao, B., 2007. b-Carotene induces apoptosis
and up-regulates peroxisome proliferator activated receptor gamma expression
and reactive oxygen species production in MCF-7 cancer cells. Eur. J. Cancer 43,
2590e2601.
Duitsman, P.K., Barua, A.B., Becker, B., Olson, J.A., 1999. Effects of epoxy carotenoids,
b-carotene, and retinoic acid on the differentiation and viability of the leukemia
cell line NB4 in vitro. Int. J. Vitam. Nutr. Res. 69, 303e308.
El-Agamey, A., Lowe, G.M., McGarvey, D.J., Mortensen, A., Phillip, D.M., Truscott, T.G.,
Young, A.J., 2004. Carotenoid radical chemistry and antioxidant/pro-oxidant
properties. Arch. Biochem. Biophys. 430, 37e48.
Emenhiser, C., Sander, L.C., Schwartz, S.J., 1995. Capability of a polymeric C30 sta-
tionary phase to resolve cis-trans carotenoid isomers in reversed-phase liquid
chromatography. J. Chromatogr. A 707, 205e216.
Eroglu, A., Harrison, E.H., 2013. Carotenoid metabolism in mammals, including
man: formation, occurrence, and function of apocarotenoids. J. Lipid Res. 54,
1719e1730.
Etminan, M., Takkouche, B., Caama~no-Isorna, F., 2004. The role of tomato products
and lycopene in the prevention of prostate cancer: a meta-analysis of obser-
vational studies. Cancer Epidemiol. Biomarkers Prev. 13, 340e345.
Ferreira, A.L., Yeumb, K.J., Russell, R.M., Krinsky, N.I., Tang, G., 2004. Enzymatic and
oxidative metabolites of lycopene. J. Nutri. Biochem. 15, 493e502.
Forbes, K., Gillette, K., Sehgal, I., 2003. Lycopene increases urokinase receptor and
fails to inhibit growth or connexin expression in a metastatically passaged
prostate cancer cell line: a brief communication. Exp. Biol. Med. 228, 967e971.
Ford, N.A., Elsen, A.C., Zuniga, K., Lindshield, B.L., Erdman Jr., J.W., 2011. Lycopene
and apo-120-lycopenal reduce cell proliferation and alter cell cycle progression
in human prostate cancer cells. Nutr. Cancer 63, 256e263.
Gajic, M., Zaripheh, S., Sun, F., Erdman Jr., J.W., 2006. Apo-80-lycopenal and apo-120-
lycopenal are metabolic products of lycopene in rat liver. J. Nutr. 136,
1552e1557.
Giovannucci, E., Rimm, E.B., Liu, Y., Stampfer, M.J., Willett, W.C., 2002. A prospective
study of tomato products, lycopene, and prostate cancer risk. J. Natl. Cancer Inst.
94, 391e398.
Gunasekera, R.S., Sewgobind, K., Desai, S., Dunn, L., Black, H.S., McKeehan, W.L.,
Patil, B., 2007. Lycopene and lutein inhibit proliferation in rat prostate carci-
noma cells. Nutr. Cancer 58, 171e177.
Halliwell, B., 1999. Establishing the signiﬁcance and optimal intake of dietary an-
tioxidants: the biomarker concept. Nutr. Rev. 57, 104e113.
Hanusch, M., Stahl, W., Schulz, W.A., Sies, H., 1995. Induction of gap junctional
communication by 4-oxoretinoic acid generated from its precursor cantha-
xanthin. Arch. Biochem. Biophys. 317, 423e428.
B.P. Arathi et al. / Food and Chemical Toxicology 97 (2016) 265e276276Herzog, A., Siler, U., Spitzer, V., Seifert, N., Denelavas, A., Hunziker, P.B., Hunziker, W.,
Goralczyk, R., Wertz, K., 2005. Lycopene reduced gene expression of steroid
targets and inﬂammatory markers in normal rat prostate. FASEB J. 19, 272e274.
Hu, X., White, K.M., Jacobsen, N.E., Mangelsdorf, D.J., Canﬁeld, L.M., 1998. Inhibition
of growth and cholesterol synthesis in breast cancer cells by oxidation products
of b-carotene. J. Nutri. Biochem. 9, 567e574.
Hu, K.Q., Liu, C., Ernst, H., Krinsky, N.I., Russell, R.M., Wang, X.D., 2006. The
biochemical characterization of ferret Carotene-9, 10-Monooxygenase cata-
lyzing cleavage of carotenoids in vitro and in vivo. J. Biol. Chem. 281,
19327e19338.
Ivanov, N.I., Cowell, S.P., Brown, P., Rennie, P.S., Guns, E.S., Cox, M.E., 2007. Lycopene
differentially induces quiescence and apoptosis in androgen-responsive and
-independent prostate cancer cell lines. Clin. Nutr. 26, 252e263.
Khachik, F., Spangler, C.J., Cecil Smith, J., 1997. Identiﬁcation, quantiﬁcation, and
relative concentrations of carotenoids and their metabolites in human milk and
serum. Anal. Chem. 69, 1873e1881.
Kim, S.J., Nara, E., Kobayashi, H., Terao, J., Nagao, A., 2001. Formation of cleavage
products by autoxidation of lycopene. Lipids 36, 191e199.
Kim, L., Rao, V., Rao, L., 2002. Effects of Lycopene on prostate LNCaP cancer cells in
culture. J. Med. Food 5, 181e187.
Kopec, R.E., Riedl, K.M., Harrison, E.H., Curley Jr., R.W., Hruszkewycz, D.P.,
Clinton, S.K., Schwartz, S.J., 2010. Identiﬁcation and quantiﬁcation of apo-
lycopenals in fruits, vegetables, and human plasma. J. Agric. Food Chem. 58,
3290e3296.
Kotake-Nara, E., Kushiro, M., Zhang, H., Sugawara, T., Miyashita, K., Nagao, A., 2001.
Carotenoids affect proliferation of human prostate Cancer cells. J. Nutr. 131,
3303e3306.
Lakshminarayana, R., Aruna, G., Sangeetha, R.K., Bhaskar, N., Divakar, S.,
Baskaran, V., 2008. Possible degradation/biotransformation of lutein in vitro
and in vivo: isolation and structural elucidation of lutein metabolites by HPLC
and LCeMS (atmospheric pressure chemical ionization). Free Radic. Biol. Med.
45, 982e993.
Lakshminarayana, R., Sathish, V., Shylaja, M.D., Baskaran, V., 2010. Antioxidant and
cytotoxic effect of oxidized lutein in human carcinoma cells (HeLa). Food Chem.
Toxicol. 48, 1811e1816.
Lakshminarayana, R., Aruna, G., Sathisha, U.V., Dharmesh, S.M., Baskaran, V., 2013.
Structural elucidation of possible lutein oxidation products mediated through
peroxyl radical inducer 2, 20-Azobis (2-methylpropionamidine) dihydro-
chloride: antioxidant and cytotoxic inﬂuence of oxidized lutein in HeLa cells.
Chem. Biol. Inter 203, 448e455.
Liu, C., Lian, F., Smith, D.E., Russell, R.M., Wang, X.D., 2003. Lycopene supplemen-
tation inhibits lung squamous metaplasia and induces apoptosis via up-
regulating insulin-like growth factor-binding protein 3 in cigarette smoke-
exposed ferrets. Cancer Res. 63, 3138e3144.
Livny, O., Kaplan, I., Reifen, R., Polak-Charcon, S., Madar, Z., Schwartz, B., 2002.
Lycopene inhibits proliferation and enhances gap-junction communication of
KB-1 human oral tumor cells. J. Nutr. 132, 3754e3759.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein estimation with
Folin phenol reagent. J. Biol. Chem. 193, 265e275.
Nahum, A., Hirsch, K., Danilenko, M., Watts, C.K.W., Prall, O.W.J., Levy, Y., Sharoni, Y.,
2001. Lycopene inhibition of cell cycle progression in breast and endometrial
cancer cells is associated with reduction in cyclin D levels and retention of
p27Kip1 in the cyclin E-cdk2 complexes. Oncogene 20, 3428e3436.
Nara, E., Hayashi, H., Kotake, M., Miyashita, K., Nagao, A., 2001. Acyclic carotenoids
and their oxidation mixtures inhibit the growth of HL-60 human promyelocytic
leukemia cells. Nutr. Cancer 39, 273e283.
Nidhi, B., Sharavana, G., Ramaprasad, T.R., Basakaran, V., 2015. Lutein derived
fragments exhibit higher antioxidant and anti-inﬂammatory properties than
lutein in lipopolysaccharide induced inﬂammation in rats. Food Funct. 6,
450e460.
Ohkawa, H., Ohishi, N., Yagi, H., 1979. Assay for lipid peroxides in animal tissues by
thiobarbituric acid reaction. Anal. Biochem. 95, 351e358.Omenn, G.S., Goodman, G.E., Thomquist, M.D., 1996. Effects of a combination of b-
carotene and vitamin A on lung cancer and cardiovascular disease. New Engl. J.
Med. 334, 1150e1155.
Palozza, P., Calviello, G., Serini, S., Maggiano, N., Lanza, P., Ranelletti, F.O.,
Bartoli, G.M., 2001. Beta-carotene at high concentrations induces apoptosis by
enhancing oxy-radical production in human adenocarcinoma cells. Free Radic.
Biol. Med. 30, 1000e1007.
Palozza, P., Serini, S., Maggiano, N., Angelini, M., Boninsegna, A., Di Nicuolo, F.,
Ranelletti, F.O., Calviello, G., 2002. Induction of cell cycle arrest and apoptosis in
human colon adenocarcinoma cell lines by b-carotene through down-
regulation of cyclin A and Bcl-2 family proteins. Carcinogenesis 23, 11e18.
Pennathur, S., Maitra, D., Byun, J., Sliskovic, I., Abdul Hamid, I., Saed, G.M.,
Diamond, M.P., Abu-Soud, H.M., 2010. Potent antioxidative activity of lycopene:
a potential role in scavenging hypochlorous acid. Free Radic. Biol. Med. 49,
205e213.
Prasad, V., Chandele, A., Jagtap, J.C., Sudheer, K.P., Shastry, P., 2006. ROS-triggered
caspase 2 activation and feedback ampliﬁcation loop in beta-carotene-induced
apoptosis. Free Radic. Biol. Med. 41, 431e442.
Rao, A.V., Agarwal, S., 2000. Role of antioxidant lycopene in cancer and heart dis-
ease. J. Am. Coll. Nutr. 19, 563e569.
Rodriguez, E.B., Rodriguez-Amaya, D.B., 2009. Lycopene epoxides and apo-
lycopenals formed by chemical reactions and autoxidation in model systems
and processed foods. J. Food Sci. 74, 674e682.
Sharoni, Y., Linnewiel-Hermoni, K., Zango, G., Khanin, M., Salman, H., Veprik, A.,
Danilenko, M., Levy, J.M., Levy, J., 2012. The role of lycopene and its derivatives
in the regulation of transcription systems: implication for cancer prevention.
Am. J. Clin. Nutr. 96, 1173Se1178S.
Siems, W., Sommerburg, O., Schild, L., Augustin, W., Langhans, C.D., Wiswedel, I.,
2002. b-carotene cleavage products induce oxidative stress in vitro by impair-
ing mitochondrial respiration. FASEB J. 16, 1289e1291.
Soares, N.C.P., Teodoro, A.J., Oliveira, F.L., Takiya, C.M., Junior, A.P., Nasciutti, L.E.,
Lotsch, P.F., Granjeiro, J.M., Ferreira, L.B., Gimba, E.R.P., Borojevic, R., 2014.
Lycopene induce apoptosis in human prostate cells and alters the expression of
Bax and Bcl-2 genes. LWT - Food Sci. Tech. 59, 1290e1297.
Sowmya, P.R., Arathi, B.P., Vijay, K., Baskaran, V., Lakshminarayana, R., 2014. Opti-
mization of LC/MS (APCI) þve methods for the determination of possible lutein
oxidation products in plasma and tissues of adult rats. Chromatographia 77,
1633e1642.
Sowmya, P.R., Arathi, B.P., Vijay, K., Baskaran, V., Lakshminarayana, R., 2015. Role of
different vehicles in carotenoids delivery and their inﬂuence on cell viability,
cell cycle progression, and induction of apoptosis in HeLa cells. Mol. Cell. Bio-
chem. 406, 245e253.
Talvas, J., Veyrat, C.C., Guy, L., Rambeau, M., Lyan, B., Quinard, R.M., 2010. Differential
effects of lycopene consumed in tomato paste and lycopene in the form of a
puriﬁed extract on target genes of cancer prostatic cells. Am. J. Clin. Nutr. 91,
1716e1724.
Tang, L., Jin, T., Zeng, X., Wang, J.S., 2005. Lycopene inhibits the growth of human
androgen-independent prostate cancer cells in vitro and in BALB/c nude mice.
J. Nutr. 135, 287e290.
Teodoro, A.J., Oliveira, F.L., Martins, N.B., Maia, G.D.A., Martucci, R.B., Borojevic, R.,
2012. Effect of lycopene on cell viability and cell cycle progression in human
cancer cell lines. Cancer Cell Int. 12, 36.
Tietze, F., 1969. Enzymatic method for quantitative determination of nano gram
amounts of total and oxidized glutathione: applications to mammalian blood
and other tissues. Anal. Biochem. 27, 502e522.
Wang, Xiang-Dong, 2012. Lycopene metabolism and its biological signiﬁcance. Am.
J. Clin. Nutr. 96, 1214Se1222S.
Wang, Xiang-Dong, Robert, M.R., 1999. Procarcinogenic and anticarcinogenic effects
of b-carotene. Nutr. Rev. 57, 263e272.
Zhang, H., Kotake-Nara, E., Ono, H., Nagao, A., 2003. A novel cleavage product
formed by autoxidation of lycopene induces apoptosis in HL-60 cells. Free
Radic. Biol. Med. 35, 1653e1663.
